Published in Am J Cardiol on November 01, 1982
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Diurnal variation of the QT interval--influence of the autonomic nervous system. Br Heart J (1986) 1.13
QT interval as a cardiac risk factor in a middle aged population. Heart (1997) 1.06
QT interval in anorexia nervosa. Br Heart J (1994) 1.01
Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography. Pflugers Arch (2013) 0.94
Frequency domain assessment of the coupling strength between ventricular repolarization duration and heart period during graded head-up tilt. J Electrocardiol (2011) 0.93
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade. J Clin Invest (1990) 0.90
QT interval and dispersion in primary autonomic failure. Heart (1996) 0.88
Computerised measurements of QT dispersion in healthy subjects. Heart (1998) 0.88
Insulin at normal physiological levels does not prolong QT(c) interval in thorough QT studies performed in healthy volunteers. Br J Clin Pharmacol (2013) 0.86
Increased QT interval variability in 3 recently concussed athletes: an exploratory observation. J Athl Train (2011) 0.82
Effect of propranolol on the QT intervals of normal individuals during exercise: a new method for studying interventions. Br Heart J (1988) 0.82
Signs of cardiac autonomic imbalance and proarrhythmic remodeling in FTO deficient mice. PLoS One (2014) 0.81
QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep (2008) 0.81
Age, altitude, and arrhythmia. Tex Heart Inst J (1995) 0.81
The epicardial electrogram: a quantitative assessment during balloon angioplasty incorporating monophasic action potential recordings. Br Heart J (1989) 0.78
QTc interval, and autonomic and somatic nerve function in diabetic neuropathy. Clin Auton Res (1998) 0.76
QT-RR hysteresis is caused by differential autonomic states during exercise and recovery. Am J Physiol Heart Circ Physiol (2012) 0.76
Abnormal autonomic modulation of QT interval in patients with idiopathic ventricular tachycardia associated with clinically normal hearts. Br Heart J (1993) 0.75
Methods of assessment and clinical relevance of QT dynamics. Indian Pacing Electrophysiol J (2005) 0.75
Effect of heart rate on QT interval in children and adolescents. Heart (1997) 0.75
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1993) 6.52
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med (1981) 3.30
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Competitive athletes with cardiovascular disease--the case of Nicholas Knapp. N Engl J Med (1998) 2.72
Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation (1992) 2.29
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Transfer from a coronary care unit. Some adverse responses. Arch Intern Med (1968) 1.97
Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol (1975) 1.93
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med (1999) 1.85
Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. Circulation (1996) 1.74
Origin of the right coronary artery from the left sinus of valsalva and its functional consequences: analysis of 10 necropsy patients. Am J Cardiol (1982) 1.73
Dissimilar atrial rhythms in man and dog. Am J Cardiol (1973) 1.61
Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation (1997) 1.58
Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol (1979) 1.55
Differential effects of cytochalasin D and 2,3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J Cardiovasc Electrophysiol (1998) 1.54
Clinical features of amiodarone-induced pulmonary toxicity. Circulation (1990) 1.49
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation (1983) 1.46
Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol (2001) 1.44
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation (2000) 1.42
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol (1995) 1.40
Epicardial maps of atrial fibrillation after linear ablation lesions. J Cardiovasc Electrophysiol (1997) 1.40
The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results. Pacing Clin Electrophysiol (1988) 1.39
Worse six-month outcome for patients with multiple stents in a single coronary artery. J Invasive Cardiol (1999) 1.39
Management of atrial fibrillation: simplicity surrounded by controversy. Ann Intern Med (1997) 1.39
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Am Heart J (1989) 1.38
Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest (1995) 1.36
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control (1984) 1.33
Different electrophysiological responses of canine endocardium and epicardium to combined hyperkalemia, hypoxia, and acidosis. Circ Res (1980) 1.33
Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol (1977) 1.33
Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ Res (1974) 1.31
Radiofrequency catheter ablation of Mahaim fibers at the tricuspid annulus. Circulation (1993) 1.29
Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness. Cardiovasc Res (1974) 1.28
Cytochalasin D as excitation-contraction uncoupler for optically mapping action potentials in wedges of ventricular myocardium. J Cardiovasc Electrophysiol (1998) 1.25
Prolongation of the Q-T interval in man during sleep. Am J Cardiol (1983) 1.25
Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy. Circulation (1979) 1.24
Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation (1988) 1.22
New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am J Cardiol (1978) 1.18
A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J (1999) 1.18
Electrophysiological remodeling of the heart owing to rate. Circulation (1997) 1.15
Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol (1996) 1.15
Unusual properties of accessory pathways. Circulation (1974) 1.14
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol (1984) 1.14
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med (1982) 1.14
Influence of the autonomic nervous system on the genesis of cardiac arrhythmias. Pacing Clin Electrophysiol (1983) 1.13
His bundle electrocardiography during bidirectional tachycardia. Circulation (1973) 1.13
Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol (1998) 1.12
Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. Circulation (1995) 1.12
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol (1997) 1.11
Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol (2000) 1.10
Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium. Circulation (1990) 1.10
Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res (1980) 1.09
Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators. Am Fam Physician (1998) 1.09
Ventricular tachycardia and ventricular fibrillation in a young population. Circulation (1979) 1.09
Mechanisms underlying the reentrant circuit of atrioventricular nodal reentrant tachycardia in isolated canine atrioventricular nodal preparation using optical mapping. Circ Res (2001) 1.08
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol (1989) 1.08
Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation (1987) 1.06
Treatment of ventricular arrhythmia by permanent atrial pacemaker and cardiac sympathectomy. Ann Intern Med (1968) 1.05
Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol (1987) 1.05
Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers. Am Heart J (1989) 1.05
Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace (2002) 1.05
Alterations in canine myocardial excitability during ischemia. Circ Res (1977) 1.05
Electrocardiographic manifestations of concealed junctional ectopic impulses. Circulation (1976) 1.05
Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation (1988) 1.05
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol (1999) 1.05
Sympathetic stimulation and arrhythmias. N Engl J Med (1991) 1.04
Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation (1980) 1.03
Second-degree atrioventricular block. Circulation (1979) 1.02
Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation (1987) 1.02
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01
Selective vagal denervation of the atria eliminates heart rate variability and baroreflex sensitivity while preserving ventricular innervation. Circulation (1998) 1.01
A consensus report on antiarrhythmic drug use. Clin Cardiol (1994) 1.01